Anti-PD-1 refractory melanoma is advanced skin cancer that no longer responds to a widely used class of immunotherapy drugs.

With an excellent half-year result of €3.9bn, Munich Re is well on track to achieve its annual target of €6.3bn. Thanks to ...

For the first time in some wealth managers’ careers, women clients began bringing up a book in meetings. Not a personal ...

Net turnover decreased by 33 % to SEK 87.6 million (130.8), attributable to lower order volumes during the period. Gross ...